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Background: The value of supporting cancer survivors beyond formal treat-
ment has become increasingly recognized among clinicians who care for
patients with head and neck cancer.
Methods: A survey was developed by the American Head and Neck Society
(AHNS) Survivorship Committee and distributed to members of the AHNS
electronically.
Results: The survey was distributed to 1403 AHNS members, with
202 responses (14.4%). Among survivorship topics, respondents were most
likely to address detection of recurrence/second primary malignancies (97.5%),
dysphagia (93.1%), and thyroid function (90.1%) with their patients; they were
least likely to address sleep disturbance/apnea (27.7%) and body and self-image
issues (29.7%.) Less than half provide patients with a written treatment sum-
mary (43.1%) or follow-up care plan (36.9%).
Conclusions: These results highlight the need for improved survivorship care
planning and offer an opportunity for the development of educational and sur-
vivorship research in head and neck cancer care.
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1 | INTRODUCTION
Cancer can have a devastating impact on its victims and
their families. In addition to the physical toll, cancer
and its treatment often result in psychological, social,
and financial burdens. This is especially true of malig-
nancies of the head and neck, given the aesthetic and
functional importance of this area. As such, it is appropri-
ate that as the treatment of head and neck cancer has
shifted from radical ablation to curative treatment that
also focuses on the preservation and restoration of func-
tion, the importance of quality of life after therapy has
become increasingly recognized.1 In 2005, the Institute of
Medicine (IOM) published the landmark report From
Cancer Patient to Cancer Survivor: Lost in Transition that
highlighted the increasing number of cancer survivors
who were understudied by the research community and
often lost to follow-up by care providers.2 In this report,
guidelines for strategies to improve the quality of life of
cancer survivors are provided. A notable recommenda-
tion was the provision of a written survivorship care plan.
Until recently, there were no standardized care plans or
treatment summaries for head and neck cancer survivors
although the Commission on Cancer (CoC) of the Ameri-
can College of Surgeons has adopted this as a quality
benchmark for cancer programs. The American Head
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and Neck Society (AHNS) recently published a primer on
survivorship in head and neck cancer that includes a
head and neck cancer treatment summary template.3
Additionally, the American Cancer Society (ACS) also
recently published a consensus statement outlining the
potential issues experienced by head and neck cancer
survivors.4 Therefore, given the recent interest in head
and neck cancer survivorship, this study was designed to
assess the current knowledge and attitudes pertaining to
survivorship among members of the AHNS.
2 | METHODS
The Survivorship Committee of the AHNS sponsored
this project. Members of the committee developed a
16-question survey. The survey covered respondent
demographics, practice patterns, and familiarity with cur-
rent recommendations related to survivorship in head
and neck cancer. The survey was electronically distrib-
uted to 1403 members of the AHNS. Data were collected
anonymously via an online SurveyMonkey poll. Descrip-
tive statistics were used to summarize variables of inter-
est. Subgroup analysis based on demographic responses
to fellowship completion, practice type, and years in prac-
tice was performed using Fisher's exact test.
3 | RESULTS
Respondent characteristics
Responses were received from 202 of the 1403 recipients
for a response rate of 14.4%. The characteristics of the
respondents are summarized in Table 1. The vast major-
ity of respondents were otolaryngologists (80.7%) and
completed fellowship training (84.1%).
Current practice
Respondents were questioned regarding their familiarity
with the ACS Care Guideline. This guideline details key
recommendations for assessment and management of
long-term issues common to survivors of head and neck
cancer. Only 55.9% of respondents expressed familiarity
with the ACS care guideline. However, when asked
whether specific survivorship issues outlined by the




How long ago did
you complete training?
<5 years 40 (19.8%)
5–14 years 63 (31.2%)
15-25 years 46 (22.8%)
>25 years 53 (26.2%)
What is your primary practice?
Academic 157 (78.1%)
Private practice 28 (13.9%)
Government 10 (5.0%)
Managed Care 6 (3.0%)
What percentage of your






TABLE 2 Assessed conditions
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guideline were addressed by respondents, a higher propor-
tion reported routinely addressing them in practice for
13 of the 20 assessed issues (Table 2). Of the survivorship
issues evaluated, respondents were most likely to address
detection of recurrence/second primary malignancy
(97.5%), dysphagia (93.1%), and thyroid function (90.1%)
while they were least likely to address sleep disturbance/
apnea (27.7%) and body and self-image issues (29.7%.)
Respondents reported maintaining close surveillance
of patients early after completion of cancer treatment. The
most frequent intervals for follow-up appointments during
the first year for patients who had completed their cancer
treatment were every 2 months (40.8%) and every 3 months
(41.3%). Only three respondents (1.5%) reported seeing
patients at 6-month intervals during the first year with
none reporting that they did not follow the patients. The
remaining 16.4% saw patients at 1-month intervals for the
first 12 months. Similarly, the majority of respondents pro-
vide active involvement in long-term surveillance with
62.9% reporting that they never discharge survivors from
their practice and only two respondents (1.0%) reporting
that they discharge survivors prior to 5 years.
Consistent with the patterns of surveillance, 77.7% of
respondents reported the head and neck surgeon as pri-
marily responsible for survivorship care of head and neck
cancer survivors. A survivorship nurse or nurse practi-
tioner was reported as primarily responsible by 12.4% of
respondents. Primary care physician (PCP), general oto-
laryngologist, radiation oncologist, and medical oncolo-
gist were reported as primarily responsible by less than
3% of respondents each. Respondents who completed fel-
lowship training (vs those who did not) reported a higher
percentage of head and neck surgeons (80.5% vs 62.5%)
and survivorship nurse/nurse practitioner (13% vs 9.4%)
as primarily responsible for head and neck survivorship
care at their institution (P = .005.) Respondents in Aca-
demic practice (vs those in private practice) reported a
higher percentage of survivorship nurse/nurse practi-
tioner (15.3% vs 0%) as primarily responsible (P = .013.)
Years in practice did not produce a statistically significant
difference in who was primarily responsible for head and
neck survivorship care.
Further questions directed at the current state of sur-
vivorship in head and neck cancer are seen in Table 3.
Despite a majority of respondents reporting familiarity
with the ACS Survivorship Care Guideline, a minority of
them reported that their patients receive written treat-
ment summaries and written follow-up care plans. These
practices were not statistically different based on fellow-
ship completion, practice setting, or years in practice.
Only 25.2% reported that a dedicated head and neck sur-
vivorship clinic exists at their institution. An additional
11.9% reported that a survivorship clinic was in develop-
ment at their institution. A dedicated head and neck sur-
vivorship clinic was much more likely to be present or in
development in the academic setting vs private practice
(43.3% vs 10.3%, P = <.001.) Finally, when asked who
should primarily manage long-term and late treatment
effects for head and neck patients with cancer, 48.0% of
respondents felt it should be the head and neck surgeon
and 40.4% felt it should a survivorship nurse/nurse prac-
titioner. The percentage of respondents who felt it should
be the radiation oncologist was 5.6% while the percentage
selecting PCP, general otolaryngologist, or medical oncol-
ogist were less than 2.5% each. These responses were not
statistically different based on fellowship completion,
practice type, or years in practice.
4 | DISCUSSION
The recent increase in incidence of oropharynx cancers
and improved overall survival has led to a significant rise
in survivors both in the United States and abroad.5,6 The
TABLE 3 State of survivorship
Question
No. of respondents (%)
Yes No
I do not know/in
development
Are you familiar with the American Cancer Society
Survivorship Care Guideline?
113 (55.9%) 89 (44.1%) 0
Does your institute have a dedicated head and neck
survivorship clinic?
51 (25.2%) 127 (62.9%) 24 (11.9%)
Do your patients receive a written treatment
summary at the completion of therapy (from you
or any member of treatment team)?
87 (43.1%) 92 (45.5%) 23 (11.4%)
Do you patients receive a written follow-up care
plan at completion of therapy (from you or any
member of the treatment team)?
73 (36.9%) 99 (50.0%) 26 (13.1%)
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ACS Survivorship Care Guideline and associated initia-
tives acknowledge the decline in quality of life that occurs
for head and neck patients with cancer both before and
after treatment and highlights the need for attention to
the sequelae of head and neck cancer diagnosis and treat-
ment well beyond the acute treatment phase.7
Our survey indicates that the impact of the IOM's
report and the ACS Survivorship Care Guideline among
primarily head and neck surgical oncologists has not been
fully realized. Just over half of respondents reported famil-
iarity with the Survivorship Care Guideline. Despite treat-
ment summaries and survivorship care plans being a CoC
quality standard, only 43% and 37% of respondents report
that their survivors receive written treatment summaries
and follow-up care plans, respectfully. This is consistent
with a recent study of oral/oropharyngeal cancer survivors
in which only 35% of those who were surveyed between
2 and 5 years after their diagnosis had received a written
treatment summary.8 This may reflect challenges with
implementation of a written process. In December of
2017, the CoC decreased the minimum required percent-
age of delivered survivorship care plans to eligible patients
for accredited programs from 75% to 50% for 2018, an indi-
cation of the state of penetrance of this initiative.
While the percentage of survivors who reported receiv-
ing a written treatment summary in the above study of
oral/oropharyngeal cancer survivors was low, 96%
reported that their physician informed them about the
need to follow up.8 In our survey, while the proportion of
respondents who are providing written treatment summa-
ries and survivorship care plans is low, the proportion of
respondents who are addressing many of the survivorship
issues is high. The detection of recurrence/second pri-
mary, dysphagia, thyroid function, and tobacco/alcohol
use were of primary interest to the respondents. However,
few providers assessed for sleep disturbance/apnea, body
and self-image issues, gastroesophageal reflux, and depres-
sion/anxiety. Tobacco and alcohol use are established risk
factors for recurrence of head and neck cancer, and dys-
phagia and thyroid dysfunction are common and well-
recognized sequelae of head and neck cancer treatments.
Therefore, it appears that the most commonly considered
survivorship needs by head and neck surgical oncology
providers are the well-established morbidities of head and
neck cancer and therapy. However, the unmet needs most
frequently mentioned by patients are psychological in
nature.9 A study of long-term caregivers of patients with
head and neck cancer also found greatest levels of unmet
needs for partners of patients to occur in the emotional
and health service domains.10 Head and neck patients
with cancer are at high risk for emotional and financial
distress, and in our survey depression/anxiety and the
associated body and self-image issues are less commonly
addressed by respondents. The incidence of depression in
patients with HNC is as high as 40%.11 Unemployment
more than doubles after treatment for head and neck can-
cer, with unemployment linked to decreased functional
and social well-being scores and increased depression
scores.12 Furthermore, the suicide rate among patients
with head and neck cancer is three times that of the
United States general population, representing the highest
suicide rate among all cancer types.13,14 Randomized con-
trolled data exist that demonstrate the development of
depression can be prophylactically reduced in patients
undergoing treatment for head and neck cancer,15 and an
important step in the treatment of any problem is recog-
nizing it. Therefore, our results suggest need for increased
attention to psychological and less common morbidities
that impact survivors.
The results of our survey reveal that head and neck
surgeons are actively involved in the surveillance of their
patients. The reported frequencies of patient visits in the
first year after completion of treatment are in line with
the recommendations by the National Comprehensive
Cancer Network guidelines,11,16 and the vast majority of
respondents continue to follow their patients for at least
5 years. The most frequently addressed topic in our sur-
vey was detection of recurrence/second primary cancer.
This corresponds with patient reported understanding in
a previous survey in which 76% of patients expressed that
the most important reason for follow-up care is to check
for recurrence.8 Interestingly, only 1% of those patients
felt that treatment for any symptom or side effect of can-
cer therapy is the most important reason for follow-up
care. However, the yield of surveillance visits in detection
of asymptomatic recurrence is low and the impact on sur-
vival is questionable, thus leading some to suggest that
follow-up visits should focus on other survivorship
issues.17,18 Furthermore, there is evidence to suggest that
the survivorship needs of patients are not adequately
being addressed outside of the head and neck specialist's
clinic. Although the ACS Survivorship Care Guideline is
directed at PCPs, in a recent survey of PCPs, only 32% felt
confident they could manage late/long term side effects
of head and neck cancer treatment and only 29% felt con-
fident they could provide appropriate cancer screening.19
Only 3% of respondents in our survey report that the PCP
is primarily responsible for survivorship care in their
patients with cancer and only 1.5% of respondents felt
the PCP should be primarily responsible for managing
long-term and late treatment effects. Furthermore, the
written treatment summaries and survivorship care plans
may not achieve their goal of educating patients and their
PCPs. A survey of patients and their physicians between
3 and 4 years after receipt of the survivorship care plan
revealed that only 10% of patients and 34% of their
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community physicians or dentists were able to locate or
recall receiving the survivorship care plan, and 90% of
patients were unsure of the value of care plans.20
It may be that utilization of written care plans and the
PCP is not the optimal way to address survivorship for
patients treated for head and neck cancer. In our survey,
12.4% of respondents report that a survivorship nurse/
nurse practitioner is currently responsible for survivorship
care while 40.4% of respondents feel that a survivorship
nurse/nurse practitioner should be primarily responsible
for managing long-term and late treatment effects. The dis-
cordance of these two numbers likely reflect acknowledge-
ment of a role for nurse practitioner led survivorship
clinics by respondents of the survey. Interestingly, there
was a higher percentage of survivorship nurse/nurse prac-
titioners (15.3% vs 0%) currently primarily responsible for
survivorship care reported in the academic setting vs pri-
vate practice, but no statistical difference for the answer of
who should be primarily responsible between the two set-
tings. This suggests that while academic centers are further
along in the establishment of survivorship clinics
(as confirmed by the percentage of academic setting vs pri-
vate practice [43.4% vs 10.3%] who have survivorship
clinics active or in development), both settings see a value.
Surgeons may be more apt to reassign their role in
follow up if the yield of asymptomatic cancer surveillance
is seen as low and the survivorship needs are seen as high
and/or better addressed by another. This may increas-
ingly be the case due to HPV-related head and neck can-
cer. Patients with HPV-related head and neck cancer are
on average younger. They also have higher cure rates and
likely have lower second primary cancer rates.21 These
factors would contribute to lower yield of cancer surveil-
lance and longer survivorship periods. The optimal struc-
ture for coordination of cancer surveillance and
survivorship care between the head and neck surgeon
and survivorship nurse practitioner and other care pro-
viders warrants further investigation.
We acknowledge the limitations of a survey study,
including recall bias. Additionally, it is recognized that the
vast majority of members of the AHNS and the respondents
to this survey are otolaryngology trained head and neck
surgeons, which biases the responses to that perspective.
5 | CONCLUSION
Responding members of the AHNS are actively involved
in the follow-up care of their patients with head and neck
cancer. However, familiarity with the ACS Survivorship
Care Guideline is low and respondents are not meeting
the current CoC accreditation minimum for provision of
written treatment summaries and survivorship care
plans. While 40% of respondents report that a survivor-
ship nurse/nurse practitioner should manage the long-
term and late treatment effects for head and neck
patients with cancer, only 25% report that a survivorship
clinic currently exists at their institution. The optimal
structure to address the unique and unmet survivorship
needs of patients following the treatment of head and
neck cancer warrants further investigation.
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